1. Acknowledgement

   Announcement 17 September 2012 Pages: 753 - 755

2. Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer

   • Eija A. Lundström
   • Rupert K. Rencken
   • Hervé C. Porchet

   Original Research Article 17 September 2012 Pages: 757 - 765

   

3. Antihypertensive Efficacy of Perindopril 5–10 mg/day in Primary Health Care

   • Dan-Dominic Ionescu
   • PREFER Investigators

   Original Research Article 17 September 2012 Pages: 767 - 776

   

4. Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users

   • Joseph Stauffer
   • Beatrice Setnik
   • Edward Sellers

   Original Research Article 17 September 2012 Pages: 777 - 790

   

5. The Role of Baseline Blood Pressure in Guiding Treatment Choice

   • James L. Pool
   • Robert Glazer
   • Drew Levy

   Original Research Article 17 September 2012 Pages: 791 - 802

   

6. Patient Satisfaction with Switching to Esomeprazole from Existing Proton Pump Inhibitor Therapy for Gastro-Oesophageal Reflux Disease

   • Robert J. Hoogendoorn
   • Lex Groeneveld
   • J. Andy Kwee

   Original Research Article 17 September 2012 Pages: 803 - 810

   

7. Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism

   • Ken Yajima
   • Akira Shimada
   • Seiko Irie

   Original Research Article 17 September 2012 Pages: 811 - 819

   

8. Abdominal Aortitis after Use of Granulocyte Colony-Stimulating Factor

   • Giridhar U. Adiga
   • Dahlia Elkadi
   • Stefan Madajewicz

   Case Report 17 September 2012 Pages: 821 - 825